Publications by authors named "Jeff Newcomb"

Claim this Profile
S
Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy.
Austin M Wheeler, Tanner J Ourada, Spencer Q Jones, Michael J Duryee, Bryant R England, Jeff Newcomb

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial.
Samantha Kohn, Harlan Sayles, Lindsay N Helget, Bryant R England, Punyasha Roul, Jeff A Newcomb

Semin Arthritis Rheum· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial.
Austin Barry, Bryant R England, Harlan Sayles, Lindsay N Helget, Maria Androsenko, Jeff A Newcomb

Arthritis Care Res (Hoboken)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gout Flares After Stopping Anti-Inflammatory Prophylaxis: A Rapid Literature Review and Meta-Analysis.
Lisa K Stamp, Christopher Frampton, Jeff A Newcomb, James R O'Dell, Ted R Mikuls

Arthritis Care Res (Hoboken)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of a structured research site mentorship model to facilitate site performance in a clinical research network.
Marcus R Johnson, Danielle Beck, Melyssa Sueiro, Makaila Decker, Jeff Newcomb

Contemp Clin Trials Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.
Lindsay N Helget, Anne Davis-Karim, James R O'Dell, Ted R Mikuls, Jeff A Newcomb

Am J Kidney Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.
Austin Barry, Lindsay N Helget, Maria Androsenko, Hongsheng Wu, Bridget Kramer, Jeff A Newcomb

Arthritis Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout.
Lindsay N Helget, James R O'Dell, Jeff A Newcomb, Maria Androsenko, Mary T Brophy

Arthritis Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Provider-Based Approach to Address Racial Disparities in Lupus Clinical Trial Participation.
Nicole I Wanty, Dexter L Cooper, Andrew Simkus, Eric C Twombly, Sheryl McCalla, Jeff Newcomb

Arthritis Care Res (Hoboken)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management.
James R O'Dell, Mary T Brophy, Michael H Pillinger, Tuhina Neogi, Paul M Palevsky, Jeff A Newcomb

NEJM Evid· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis